Top Institutions in Endocrinology and Ophthalmology
Leading institutions conduct large-scale cardiovascular outcome trials (CVOTs), meta-analyses, and post hoc mediation analyses to evaluate the safety and efficacy of GLP-1RAs in diabetic populations, integrating endocrinology and ophthalmology expertise to assess DR progression.
-
#1
Joslin Diabetes Center
Boston, MA
Joslin is a world leader in diabetes research with extensive expertise in diabetic complications including retinopathy, conducting pivotal clinical trials and translational research on diabetes medications such as GLP-1RAs.
-
#2
Mayo Clinic
Rochester, MN
Mayo Clinic integrates multidisciplinary clinical research in diabetes and eye diseases, leading numerous cardiovascular and diabetic retinopathy outcome trials involving GLP-1RA therapies.
-
#3
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is recognized for its translational research in diabetes and diabetic eye disease, contributing to understanding the mechanisms linking GLP-1RA therapy and diabetic retinopathy progression.
-
#4
Massachusetts General Hospital (MGH)
Boston, MA
MGH has a robust clinical research infrastructure supporting large-scale diabetes and ophthalmology trials, contributing to the evidence base on GLP-1RA safety profiles and diabetic retinopathy outcomes.
-
#5
Johns Hopkins University
Baltimore, MD
Johns Hopkins conducts interdisciplinary research on diabetes complications, including diabetic retinopathy, with a focus on pharmacologic impacts of new diabetes therapies like GLP-1RAs.